US EditionPublished • loading... • Updated
Metformin vs Dapagliflozin: Heart Protection in Diabetic Rats
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGMetformin vs Dapagliflozin: Heart Protection in Diabetic Rats
In a groundbreaking study poised to reshape our understanding of cardio-protection in diabetic patients, researchers have delivered an in-depth comparison between metformin and dapagliflozin, two cornerstone drugs in diabetes management, exploring their roles in mitigating myocardial infarction. Conducted on diabetic rodent models, the investigation dives deep into the pharmacological nuances and therapeutic potentials of these agents against ca…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
